MicroRNA-155 reinforces HIV latency

Journal of Biological Chemistry

Volumn 290, Issue 22, 2015, Pages 13736-13748

  Ruelas, Debbie S ^a,b   Chan, Jonathan K ^a   Oh, Eugene ^d   Heidersbach, Amy J ^b,e   Hebbeler, Andrew M ^a   Chavez, Leonard ^a,b   Verdin, Eric ^a,c   Rape, Michael ^d   Greene, Warner C ^a,c  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELLS; CHEMICAL ACTIVATION; CURING; GENE EXPRESSION; RNA;

CYTOPATHIC EFFECT; INFECTED CELLS; KINASE ACTIVATION; MICRORNAS; UBIQUITIN LIGASES;

CYTOLOGY;

DICER; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 1290; MICRORNA 146A; MICRORNA 155; MICRORNA 221; MICRORNA 29B; MICRORNA 505; MICRORNA 518B; MICRORNA 885 5P; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RELA; TRIPARTITE MOTIF CONTAINING PROTEIN 32; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; I KAPPA B; MIRN155 MICRORNA, HUMAN; NF-KAPPAB INHIBITOR ALPHA; TRANSCRIPTION FACTOR; TRIM25 PROTEIN, HUMAN; TRIM32 PROTEIN, HUMAN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

3' UNTRANSLATED REGION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; RNA ANALYSIS; TRANSCRIPTION INITIATION; UPREGULATION; VIRUS INHIBITION; VIRUS LATENCY; VIRUS REACTIVATION; CELL DEATH; CHEMISTRY; LENTIVIRINAE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN MOTIF; REPORTER GENE; SEQUENCE HOMOLOGY; VIROLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

3' UNTRANSLATED REGIONS; AMINO ACID MOTIFS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; GENE SILENCING; GENES, REPORTER; HIV-1; HUMANS; I-KAPPA B PROTEINS; LENTIVIRUS; MICRORNAS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84930226422     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.641837     Document Type: Article

References (50)

1. Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., and Ho, D. D. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191
2. Chun, T. W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., and Siliciano, R. F. (1995) In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1, 1284-1290
3. Colin, L., and Van Lint, C. (2009) Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6, 111
4. Williams, S. A., Chen, L. F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., and Greene, W. C. (2004) Prostratin antagonizes HIV latency by activating NF-κB. J. Biol. Chem. 279, 42008-42017
5. Jordan, A., Bisgrove, D., and Verdin, E. (2003) HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868-1877
6. Chan, J. K., Bhattacharyya, D., Lassen, K. G., Ruelas, D., and Greene, W. C. (2013) Calcium/calcineurin synergizes with prostratin to promote NF-κB dependent activation of latent HIV. PLoS One 8, e77749
7. Spina, C. A., Anderson, J., Archin, N. M., Bosque, A., Chan, J., Famiglietti, M., Greene, W. C., Kashuba, A., Lewin, S. R., Margolis, D. M., Mau, M., Ruelas, D., Saleh, S., Shirakawa, K., Siliciano, R. F., Singhania, A., Soto, P. C., Terry, V. H., Verdin, E., Woelk, C., Wooden, S., Xing, S., and Planelles, V. (2013) An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog. 9, e1003834
8. Triboulet, R., Mari, B., Lin, Y. L., Chable-Bessia, C., Bennasser, Y., Lebrigand, K., Cardinaud, B., Maurin, T., Barbry, P., Baillat, V., Reynes, J., Corbeau, P., Jeang, K. T., and Benkirane, M. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315, 1579-1582
9. Chiang, K., Sung, T. L., and Rice, A. P. (2012) Regulation of cyclin T1 and HIV-1 replication by microRNAs in resting CD4+ T lymphocytes. J. Virol. 86, 3244-3252
10. Swaminathan, G., Rossi, F., Sierra, L. J., Gupta, A., Navas-Martín, S., and Martín-García, J. (2012) A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog. 8, e1002937
11. Huang, J., Wang, F., Argyris, E., Chen, K., Liang, Z., Tian, H., Huang, W., Squires, K., Verlinghieri, G., and Zhang, H. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13, 1241-1247
12. Nathans, R., Chu, C. Y., Serquina, A. K., Lu, C. C., Cao, H., and Rana, T. M. (2009) Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34, 696-709
13. Schwamborn, J. C., Berezikov, E., and Knoblich, J. A. (2009) The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 136, 913-925
14. Zhang, J., Hu, M. M., Wang, Y. Y., and Shu, H. B. (2012) TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J. Biol. Chem. 287, 28646-28655
15. Albor, A., El-Hizawi, S., Horn, E. J., Laederich, M., Frosk, P., Wrogemann, K., and Kulesz-Martin, M. (2006) The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFκB. J. Biol. Chem. 281, 25850-25866
16. Uchil, P. D., Hinz, A., Siegel, S., Coenen-Stass, A., Pertel, T., Luban, J., and Mothes, W. (2013) TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 87, 257-272
17. Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267
18. Ryu, Y. S., Lee, Y., Lee, K. W., Hwang, C. Y., Maeng, J. S., Kim, J. H., Seo, Y. S., You, K. H., Song, B., and Kwon, K. S. (2011) TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP). J. Biol. Chem. 286, 25729-25738
19. Sun, S., Elwood, J., and Greene, W. C. (1996) Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16, 1058-1065
20. Calvanese, V., Chavez, L., Laurent, T., Ding, S., and Verdin, E. (2013) Dual-color HIV reporters trace a population of latently infected cells and enable their purification. Virology 446, 283-292
21. Fridell, R. A., Harding, L. S., Bogerd, H. P., and Cullen, B. R. (1995) Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology 209, 347-357
22. Loeb, G. B., Khan, A. A., Canner, D., Hiatt, J. B., Shendure, J., Darnell, R. B., Leslie, C. S., and Rudensky, A. Y. (2012) Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 48, 760-770
23. Jordan, A., Defechereux, P., and Verdin, E. (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20, 1726-1738
24. Kwon, H., Pelletier, N., DeLuca, C., Genin, P., Cisternas, S., Lin, R., Wainberg, M. A., and Hiscott, J. (1998) Inducible expression of IκBα repressor mutants interferes with NF-κB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273, 7431-7440
25. Archin, N. M., and Margolis, D. M. (2014) Emerging strategies to deplete the HIV reservoir. Curr. Opin. Infect. Dis. 27, 29-35
26. Ho, Y. C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I., Lai, J., Blankson, J. N., Siliciano, J. D., and Siliciano, R. F. (2013) Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540-551
27. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126
28. Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H. C., Zhang, H., Margolick, J. B., Blankson, J. N., and Siliciano, R. F. (2012) Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491-501
29. Descours, B., Avettand-Fenoel, V., Blanc, C., Samri, A., Mélard, A., Supervie, V., Theodorou, I., Carcelain, G., Rouzioux, C., Autran, B., and ALT ANRS CO15 Study Group (2012) Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin. Infect. Dis. 54, 1495-1503
30. Nettles, R. E., Kieffer, T. L., Kwon, P., Monie, D., Han, Y., Parsons, T., Cofrancesco, J., Jr., Gallant, J. E., Quinn, T. C., Jackson, B., Flexner, C., Carson, K., Ray, S., Persaud, D., and Siliciano, R. F. (2005) Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA 293, 817-829
31. Dornadula, G., Zhang, H., VanUitert, B., Stern, J., Livornese, L., Jr., Ingerman, M. J., Witek, J., Kedanis, R. J., Natkin, J., DeSimone, J., and Pomerantz, R. J. (1999) Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 282, 1627-1632
32. Banerjee, A., Schambach, F., DeJong, C. S., Hammond, S. M., and Reiner, S. L. (2010) Micro-RNA-155 inhibits IFN-γ signaling in CD4+ T cells. Eur. J. Immunol. 40, 225-231
33. Haasch, D., Chen, Y. W., Reilly, R. M., Chiou, X. G., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W., Djuric, S. W., and Trevillyan, J. M. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell. Immunol. 217, 78-86
34. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., Vetrie, D., Okkenhaug, K., Enright, A. J., Dougan, G., Turner, M., and Bradley, A. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611
35. Thai, T. H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., Schmidt-Supprian, M., Rajewsky, N., Yancopoulos, G., Rao, A., and Rajewsky, K. (2007) Regulation of the germinal center response by microRNA-155. Science 316, 604-608
36. Lu, F., Weidmer, A., Liu, C. G., Volinia, S., Croce, C. M., and Lieberman, P. M. (2008) Epstein-Barr virus-induced miR-155 attenuates NF-κB signaling and stabilizes latent virus persistence. J. Virol. 82, 10436-10443
37. Linnstaedt, S. D., Gottwein, E., Skalsky, R. L., Luftig, M. A., and Cullen, B. R. (2010) Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84, 11670-11678
38. Gottwein, E. (2013) Roles of microRNAs in the life cycles of mammalian viruses. Curr. Top. Microbiol. Immunol. 371, 201-227
39. Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W. H., Chi, J. T., Braich, R., Manoharan, M., Soutschek, J., Ohler, U., and Cullen, B. R. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450, 1096-1099
40. Skalsky, R. L., Samols, M. A., Plaisance, K. B., Boss, I. W., Riva, A., Lopez, M. C., Baker, H. V., and Renne, R. (2007) Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81, 12836-12845
41. So, A. Y., Zhao, J. L., and Baltimore, D. (2013) The Yin and Yang of microRNAs: leukemia and immunity. Immunol. Rev. 253, 129-145
42. Lu, L. F., Thai, T. H., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G. B., Lee, H., Yoshimura, A., Rajewsky, K., and Rudensky, A. Y. (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91
43. Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., and Weiner, H. L. (2011) Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 187, 2213-2221
44. O'Connell, R. M., Kahn, D., Gibson, W. S., Round, J. L., Scholz, R. L., Chaudhuri, A. A., Kahn, M. E., Rao, D. S., and Baltimore, D. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619
45. Bartel, D. P., and Chen, C. Z. (2004) Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396-400
46. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., and Burge, C. B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798
47. Deshaies, R. J., and Joazeiro, C. A. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434
48. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., and Ben-Neriah, Y. (1998) Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396, 590-594
49. Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., and Harper, J. W. (1999) The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13, 270-283
50. Spencer, E., Jiang, J., and Chen, Z. J. (1999) Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes Dev. 13, 284-294